Skip to main content
TipRanks
Go Ultimate75% OFF

OrthoPediatrics (2X7) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2X7 Analyst Ratings

Strong Buy
7Ratings
6Buy1Hold0Sell
Based on 7 analysts giving stock ratings to OrthoPediatrics in the past 3 months

2X7 Stock 12 Month Forecast

€27.34▼(-5.06% Downside)
Based on 7 Wall Street analysts offering 12 month price targets for OrthoPediatrics in the last 3 months. The average price target is EUR 27.34 with a high forecast of EUR 34.47 and a low forecast of EUR 24.49. The average price target represents a -5.06% change from the last price of EUR 28.80.
Highest Price Target€34.47Average Price Target€27.34Lowest Price Target€24.49

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:2X7
Price TargetArticle
BTIG€26.31→€27.21buy-5.51%DownsideReiterated10/28/26
Canaccord Genuity€25.40→€27.21buy-5.51%DownsideReiterated10/28/26
Piper Sandler€22.68→€27.21buy-5.51%DownsideReiterated10/28/26
Stifel Nicolaus€21.77→€24.49buy-14.95%DownsideReiterated10/28/26
TD Cowen€20.86→€25.40buy-11.80%DownsideReiterated10/28/26
Lake Street€30.84→€34.47buy19.69%UpsideReiterated10/28/26
Truist Financial€19.96→€25.40hold-11.80%DownsideReiterated10/28/26
Needham€31.75buy10.24%UpsideReiterated08/05/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering OrthoPediatrics

3 Months
Matthew O'Brien
Matthew O'BrienPiper Sandler
Success Rate9/17 ratings generated profit
53%
Average Return
+2.86%

Copying Matthew O'Brien's trades and holding each position for 3 Months would result in 52.94% of your transactions generating a profit, with an average return of +2.86% per trade.

1 Year
Matthew O'Brien
Matthew O'BrienPiper Sandler
Success Rate7/17 ratings generated profit
41%
Average Return
-0.41%

Copying Matthew O'Brien's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of -0.41% per trade.

2 Years
Success Rate13/27 ratings generated profit
48%
Average Return
+9.32%

Copying Ryan Zimmerman's trades and holding each position for 2 Years would result in 48.15% of your transactions generating a profit, with an average return of +9.32% per trade.

2X7 Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 2X7
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy42220
Buy5108147
Hold22221
Sell00000
Strong Sell00000
total111412188

In the current month, 2X7 has received 7 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 2X7 average Analyst price target in the past 3 months is 27.34.

2X7 Financial Forecast

€-2€-1.5€-1€-0.5€0Q1 2026Q3 2026Q4 2026
High€-0.15
Consensus€-0.19
Low€-0.23

2X7 Earnings Forecast

Next quarter’s earnings estimate for 2X7 is -EUR 0.19 with a range of -EUR 0.23 to -EUR 0.15. The previous quarter’s EPS was -EUR 0.22. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

€53.2M€56.1M€59.1M€62.1M€65.1MQ1 2026Q3 2026Q4 2026
High€62.2M
Consensus€61.8M
Low€61.3M

2X7 Sales Forecast

Next quarter’s sales forecast for 2X7 is EUR 61.83M with a range of EUR 61.33M to EUR 62.19M. The previous quarter’s sales results were EUR 65.06M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2X7 Stock Forecast FAQ

What is DE:2X7’s average 12-month price target, according to analysts?
Based on analyst ratings, OrthoPediatrics’s 12-month average price target is €27.34.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OrthoPediatrics a Buy, Sell or Hold?
OrthoPediatrics has a consensus rating of Strong Buy, which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
What is OrthoPediatrics’s share price target?
The average share price target for OrthoPediatrics is €27.34. This is based on 7 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €34.47, and the lowest forecast is €24.49. The average share price target represents a 5.06% decrease from the current price of €28.8.
What do analysts say about OrthoPediatrics?
OrthoPediatrics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Street analysts.
How can I buy shares of OrthoPediatrics?
To buy shares of DE:2X7, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.